Pacific Biosciences Of California (PACB) Finished Goods (2011 - 2026)

Pacific Biosciences Of California's Finished Goods history runs 16 years deep, the most recent figure standing at $17.8 million for Q1 2026.

• On a quarterly basis, Finished Goods rose 32.83% year-over-year to $17.8 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 32.83% increase from a year earlier, with the FY2025 full-year figure at $15.7 million, up 11.56% from the prior year.
• Finished Goods climbed to $17.8 million in Q1 2026 per PACB's latest filing, from $15.7 million in the prior quarter.
• Across five years, Finished Goods topped out at $19.8 million in Q2 2023 and bottomed at $7.9 million in Q2 2022.
• The 5-year median for Finished Goods is $15.7 million (2025), against an average of $14.6 million.
• Across the five-year window, Finished Goods jumped 151.65% in 2023 and slipped 18.18% in 2025, its largest moves.
• Year by year, Finished Goods stood at $12.2 million in 2022, then climbed by 29.28% to $15.7 million in 2023, then dropped by 10.57% to $14.1 million in 2024, then gained by 11.56% to $15.7 million in 2025, then climbed by 13.55% to $17.8 million in 2026.
• Per Business Quant, the three latest PACB Finished Goods figures stand at $17.8 million (Q1 2026), $15.7 million (Q4 2025), and $16.4 million (Q3 2025).